世界の高コレステロール血症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hypercholesterolemia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2990 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、高コレステロール血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・高コレステロール血症治療の市場動向 ・企業の競争状況、市場シェア ・高コレステロール血症治療の種類別市場規模（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他） ・高コレステロール血症治療の用途別市場規模（クリニック、病院、その他） ・高コレステロール血症治療の北米市場規模2016-2027（アメリカ、カナダ） ・高コレステロール血症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・高コレステロール血症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・高コレステロール血症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・高コレステロール血症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CymaBay Therapeutics Inc、Daewoong Co Ltd、Gemphire Therapeutics Inc、LipimetiX Development Inc、Regeneron Pharmaceuticals Inc、RegenxBio Inc、The Medicines Company） ・結論

Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases. Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity. In case of genetic factors, the number of copies of the gene determines the severity of the disease. People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.

Market Analysis and Insights: Global Hypercholesterolemia Treatment Market
The global Hypercholesterolemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypercholesterolemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypercholesterolemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypercholesterolemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypercholesterolemia Treatment market.

Global Hypercholesterolemia Treatment Scope and Market Size
Hypercholesterolemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypercholesterolemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
AEM-2802
AEM-2814
Alirocumab
Evinacumab
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
RegenxBio Inc
The Medicines Company

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypercholesterolemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AEM-2802
1.2.3 AEM-2814
1.2.4 Alirocumab
1.2.5 Evinacumab
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hypercholesterolemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hypercholesterolemia Treatment Market Perspective (2016-2027)
2.2 Hypercholesterolemia Treatment Growth Trends by Regions
2.2.1 Hypercholesterolemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hypercholesterolemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hypercholesterolemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hypercholesterolemia Treatment Industry Dynamic
2.3.1 Hypercholesterolemia Treatment Market Trends
2.3.2 Hypercholesterolemia Treatment Market Drivers
2.3.3 Hypercholesterolemia Treatment Market Challenges
2.3.4 Hypercholesterolemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hypercholesterolemia Treatment Players by Revenue
3.1.1 Global Top Hypercholesterolemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Hypercholesterolemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hypercholesterolemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypercholesterolemia Treatment Revenue
3.4 Global Hypercholesterolemia Treatment Market Concentration Ratio
3.4.1 Global Hypercholesterolemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypercholesterolemia Treatment Revenue in 2020
3.5 Hypercholesterolemia Treatment Key Players Head office and Area Served
3.6 Key Players Hypercholesterolemia Treatment Product Solution and Service
3.7 Date of Enter into Hypercholesterolemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hypercholesterolemia Treatment Breakdown Data by Type
4.1 Global Hypercholesterolemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hypercholesterolemia Treatment Forecasted Market Size by Type (2022-2027)

5 Hypercholesterolemia Treatment Breakdown Data by Application
5.1 Global Hypercholesterolemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hypercholesterolemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hypercholesterolemia Treatment Market Size (2016-2027)
6.2 North America Hypercholesterolemia Treatment Market Size by Type
6.2.1 North America Hypercholesterolemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Hypercholesterolemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Hypercholesterolemia Treatment Market Size by Type (2016-2027)
6.3 North America Hypercholesterolemia Treatment Market Size by Application
6.3.1 North America Hypercholesterolemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Hypercholesterolemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Hypercholesterolemia Treatment Market Size by Application (2016-2027)
6.4 North America Hypercholesterolemia Treatment Market Size by Country
6.4.1 North America Hypercholesterolemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Hypercholesterolemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hypercholesterolemia Treatment Market Size (2016-2027)
7.2 Europe Hypercholesterolemia Treatment Market Size by Type
7.2.1 Europe Hypercholesterolemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hypercholesterolemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hypercholesterolemia Treatment Market Size by Type (2016-2027)
7.3 Europe Hypercholesterolemia Treatment Market Size by Application
7.3.1 Europe Hypercholesterolemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hypercholesterolemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hypercholesterolemia Treatment Market Size by Application (2016-2027)
7.4 Europe Hypercholesterolemia Treatment Market Size by Country
7.4.1 Europe Hypercholesterolemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hypercholesterolemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hypercholesterolemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hypercholesterolemia Treatment Market Size by Type
8.2.1 Asia-Pacific Hypercholesterolemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hypercholesterolemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hypercholesterolemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hypercholesterolemia Treatment Market Size by Application
8.3.1 Asia-Pacific Hypercholesterolemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hypercholesterolemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hypercholesterolemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hypercholesterolemia Treatment Market Size by Region
8.4.1 Asia-Pacific Hypercholesterolemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hypercholesterolemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hypercholesterolemia Treatment Market Size (2016-2027)
9.2 Latin America Hypercholesterolemia Treatment Market Size by Type
9.2.1 Latin America Hypercholesterolemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hypercholesterolemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hypercholesterolemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Hypercholesterolemia Treatment Market Size by Application
9.3.1 Latin America Hypercholesterolemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hypercholesterolemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hypercholesterolemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Hypercholesterolemia Treatment Market Size by Country
9.4.1 Latin America Hypercholesterolemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hypercholesterolemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hypercholesterolemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hypercholesterolemia Treatment Market Size by Type
10.2.1 Middle East & Africa Hypercholesterolemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hypercholesterolemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hypercholesterolemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hypercholesterolemia Treatment Market Size by Application
10.3.1 Middle East & Africa Hypercholesterolemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hypercholesterolemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hypercholesterolemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hypercholesterolemia Treatment Market Size by Country
10.4.1 Middle East & Africa Hypercholesterolemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hypercholesterolemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 CymaBay Therapeutics Inc
11.1.1 CymaBay Therapeutics Inc Company Details
11.1.2 CymaBay Therapeutics Inc Business Overview
11.1.3 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Introduction
11.1.4 CymaBay Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021)
11.1.5 CymaBay Therapeutics Inc Recent Development
11.2 Daewoong Co Ltd
11.2.1 Daewoong Co Ltd Company Details
11.2.2 Daewoong Co Ltd Business Overview
11.2.3 Daewoong Co Ltd Hypercholesterolemia Treatment Introduction
11.2.4 Daewoong Co Ltd Revenue in Hypercholesterolemia Treatment Business (2016-2021)
11.2.5 Daewoong Co Ltd Recent Development
11.3 Gemphire Therapeutics Inc
11.3.1 Gemphire Therapeutics Inc Company Details
11.3.2 Gemphire Therapeutics Inc Business Overview
11.3.3 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Introduction
11.3.4 Gemphire Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021)
11.3.5 Gemphire Therapeutics Inc Recent Development
11.4 LipimetiX Development Inc
11.4.1 LipimetiX Development Inc Company Details
11.4.2 LipimetiX Development Inc Business Overview
11.4.3 LipimetiX Development Inc Hypercholesterolemia Treatment Introduction
11.4.4 LipimetiX Development Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021)
11.4.5 LipimetiX Development Inc Recent Development
11.5 Regeneron Pharmaceuticals Inc
11.5.1 Regeneron Pharmaceuticals Inc Company Details
11.5.2 Regeneron Pharmaceuticals Inc Business Overview
11.5.3 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Introduction
11.5.4 Regeneron Pharmaceuticals Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021)
11.5.5 Regeneron Pharmaceuticals Inc Recent Development
11.6 RegenxBio Inc
11.6.1 RegenxBio Inc Company Details
11.6.2 RegenxBio Inc Business Overview
11.6.3 RegenxBio Inc Hypercholesterolemia Treatment Introduction
11.6.4 RegenxBio Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021)
11.6.5 RegenxBio Inc Recent Development
11.7 The Medicines Company
11.7.1 The Medicines Company Company Details
11.7.2 The Medicines Company Business Overview
11.7.3 The Medicines Company Hypercholesterolemia Treatment Introduction
11.7.4 The Medicines Company Revenue in Hypercholesterolemia Treatment Business (2016-2021)
11.7.5 The Medicines Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hypercholesterolemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AEM-2802
Table 3. Key Players of AEM-2814
Table 4. Key Players of Alirocumab
Table 5. Key Players of Evinacumab
Table 6. Key Players of Others
Table 7. Global Hypercholesterolemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hypercholesterolemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hypercholesterolemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hypercholesterolemia Treatment Market Share by Regions (2016-2021)
Table 11. Global Hypercholesterolemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hypercholesterolemia Treatment Market Share by Regions (2022-2027)
Table 13. Hypercholesterolemia Treatment Market Trends
Table 14. Hypercholesterolemia Treatment Market Drivers
Table 15. Hypercholesterolemia Treatment Market Challenges
Table 16. Hypercholesterolemia Treatment Market Restraints
Table 17. Global Hypercholesterolemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hypercholesterolemia Treatment Market Share by Players (2016-2021)
Table 19. Global Top Hypercholesterolemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypercholesterolemia Treatment as of 2020)
Table 20. Ranking of Global Top Hypercholesterolemia Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hypercholesterolemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hypercholesterolemia Treatment Product Solution and Service
Table 24. Date of Enter into Hypercholesterolemia Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hypercholesterolemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hypercholesterolemia Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Hypercholesterolemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hypercholesterolemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hypercholesterolemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hypercholesterolemia Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Hypercholesterolemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hypercholesterolemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hypercholesterolemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hypercholesterolemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hypercholesterolemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hypercholesterolemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hypercholesterolemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hypercholesterolemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hypercholesterolemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hypercholesterolemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hypercholesterolemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hypercholesterolemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hypercholesterolemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hypercholesterolemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hypercholesterolemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hypercholesterolemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hypercholesterolemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hypercholesterolemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hypercholesterolemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hypercholesterolemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hypercholesterolemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hypercholesterolemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hypercholesterolemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hypercholesterolemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hypercholesterolemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hypercholesterolemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hypercholesterolemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hypercholesterolemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hypercholesterolemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hypercholesterolemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hypercholesterolemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hypercholesterolemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. CymaBay Therapeutics Inc Company Details
Table 65. CymaBay Therapeutics Inc Business Overview
Table 66. CymaBay Therapeutics Inc Hypercholesterolemia Treatment Product
Table 67. CymaBay Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021) & (US$ Million)
Table 68. CymaBay Therapeutics Inc Recent Development
Table 69. Daewoong Co Ltd Company Details
Table 70. Daewoong Co Ltd Business Overview
Table 71. Daewoong Co Ltd Hypercholesterolemia Treatment Product
Table 72. Daewoong Co Ltd Revenue in Hypercholesterolemia Treatment Business (2016-2021) & (US$ Million)
Table 73. Daewoong Co Ltd Recent Development
Table 74. Gemphire Therapeutics Inc Company Details
Table 75. Gemphire Therapeutics Inc Business Overview
Table 76. Gemphire Therapeutics Inc Hypercholesterolemia Treatment Product
Table 77. Gemphire Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021) & (US$ Million)
Table 78. Gemphire Therapeutics Inc Recent Development
Table 79. LipimetiX Development Inc Company Details
Table 80. LipimetiX Development Inc Business Overview
Table 81. LipimetiX Development Inc Hypercholesterolemia Treatment Product
Table 82. LipimetiX Development Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021) & (US$ Million)
Table 83. LipimetiX Development Inc Recent Development
Table 84. Regeneron Pharmaceuticals Inc Company Details
Table 85. Regeneron Pharmaceuticals Inc Business Overview
Table 86. Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Product
Table 87. Regeneron Pharmaceuticals Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021) & (US$ Million)
Table 88. Regeneron Pharmaceuticals Inc Recent Development
Table 89. RegenxBio Inc Company Details
Table 90. RegenxBio Inc Business Overview
Table 91. RegenxBio Inc Hypercholesterolemia Treatment Product
Table 92. RegenxBio Inc Revenue in Hypercholesterolemia Treatment Business (2016-2021) & (US$ Million)
Table 93. RegenxBio Inc Recent Development
Table 94. The Medicines Company Company Details
Table 95. The Medicines Company Business Overview
Table 96. The Medicines Company Hypercholesterolemia Treatment Product
Table 97. The Medicines Company Revenue in Hypercholesterolemia Treatment Business (2016-2021) & (US$ Million)
Table 98. The Medicines Company Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypercholesterolemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. AEM-2802 Features
Figure 3. AEM-2814 Features
Figure 4. Alirocumab Features
Figure 5. Evinacumab Features
Figure 6. Others Features
Figure 7. Global Hypercholesterolemia Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Hypercholesterolemia Treatment Report Years Considered
Figure 12. Global Hypercholesterolemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Hypercholesterolemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hypercholesterolemia Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Hypercholesterolemia Treatment Market Share by Regions (2022-2027)
Figure 16. Global Hypercholesterolemia Treatment Market Share by Players in 2020
Figure 17. Global Top Hypercholesterolemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypercholesterolemia Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Hypercholesterolemia Treatment Revenue in 2020
Figure 19. Global Hypercholesterolemia Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Hypercholesterolemia Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Hypercholesterolemia Treatment Market Share by Type (2016-2027)
Figure 23. North America Hypercholesterolemia Treatment Market Share by Application (2016-2027)
Figure 24. North America Hypercholesterolemia Treatment Market Share by Country (2016-2027)
Figure 25. United States Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hypercholesterolemia Treatment Market Share by Type (2016-2027)
Figure 29. Europe Hypercholesterolemia Treatment Market Share by Application (2016-2027)
Figure 30. Europe Hypercholesterolemia Treatment Market Share by Country (2016-2027)
Figure 31. Germany Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hypercholesterolemia Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Hypercholesterolemia Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Hypercholesterolemia Treatment Market Share by Region (2016-2027)
Figure 41. China Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hypercholesterolemia Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Hypercholesterolemia Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Hypercholesterolemia Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hypercholesterolemia Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Hypercholesterolemia Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Hypercholesterolemia Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Hypercholesterolemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. CymaBay Therapeutics Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2016-2021)
Figure 61. Daewoong Co Ltd Revenue Growth Rate in Hypercholesterolemia Treatment Business (2016-2021)
Figure 62. Gemphire Therapeutics Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2016-2021)
Figure 63. LipimetiX Development Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2016-2021)
Figure 64. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2016-2021)
Figure 65. RegenxBio Inc Revenue Growth Rate in Hypercholesterolemia Treatment Business (2016-2021)
Figure 66. The Medicines Company Revenue Growth Rate in Hypercholesterolemia Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---